Mary J. Kuhn

Mary J. Kuhn is a declared insider of Talecris Biotherapeutics Holdings Corp., with filings sourced from SEC (Form 4). In total, 16 filings cover trades dated from 30 September 2009 to 1 June 2011.

Sales make up the whole of the open-market record (6 sales, €4.9M). Other entries cover 4 share grants and 5 option exercises. So far in 2011, the count stands at no purchases and 2 sales.

On 3 June 2011 came the latest disclosure, a transaction in Talecris Biotherapeutics Holdings Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.